On CNBC’s "Mad Money Lightning Round," Jim Cramer believes in GSK plc (NYSE: GSK).
"I think GSK is going even higher than it is right now," he said. "It’s been a terrific winner of late."
GSK recently resolved a U.S. lawsuit concerning its heartburn medicine Zantac shortly before the scheduled trial in California. The company reached a confidential settlement with plaintiff David Browne, leading to the dismissal of his case, which was set for Feb. 20.
When asked about AST SpaceMobile, Inc. (NASDAQ: ASTS), Cramer said, "I don’t see any way shape or form that they’re going to be making money, so I’m going to have to hold off that one."
AST SpaceMobile, ...